120 related articles for article (PubMed ID: 2142248)
1. Antitumor effects of combination toremifene and medroxyprogesterone acetate (MPA) in vitro and in vivo.
Kangas L; Grönroos M
J Steroid Biochem; 1990 Jun; 36(3):253-7. PubMed ID: 2142248
[TBL] [Abstract][Full Text] [Related]
2. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
Tominaga T; Yoshida Y; Kitamura M; Kosaki G
Jpn J Cancer Res; 1985 Nov; 76(11):1120-5. PubMed ID: 2935517
[TBL] [Abstract][Full Text] [Related]
3. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.
Zanardi S; De Menech R; Pino G; Guarneri D; Dandolo G; Sanguineti M; Moro MG; Barbi GP; Paganuzzi M; Boccardo F
Chemioterapia; 1985 Jun; 4(3):239-42. PubMed ID: 3161642
[TBL] [Abstract][Full Text] [Related]
4. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
Iino Y; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
[TBL] [Abstract][Full Text] [Related]
5. Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
Dauvois S; Spinola PG; Labrie F
Eur J Cancer Clin Oncol; 1989 May; 25(5):891-7. PubMed ID: 2525471
[TBL] [Abstract][Full Text] [Related]
6. Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat.
di Salle E; Zaccheo T; Ornati G
J Steroid Biochem; 1990 Jun; 36(3):203-6. PubMed ID: 2142233
[TBL] [Abstract][Full Text] [Related]
7. [Combined therapies with medroxyprogesterone acetate (MPA) in DMBA-induced rat mammary cancer].
Ishikawa H; Iino Y; Izuo M; Takikawa H
Gan No Rinsho; 1986 Feb; 32(2):151-5. PubMed ID: 2937941
[TBL] [Abstract][Full Text] [Related]
8. Additive and synergistic antitumor effects with toremifene and interferons.
Kangas L; Cantell K; Schellekens H
J Steroid Biochem; 1990 Jun; 36(3):259-62. PubMed ID: 2142249
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of combination medical endocrine therapy on DMBA-induced mammary tumor, with special reference to the effect of drug-dose on various factors].
Kosaka A; Yamashita A
Gan To Kagaku Ryoho; 1992 Jan; 19(1):75-81. PubMed ID: 1530907
[TBL] [Abstract][Full Text] [Related]
10. Combined and sequential treatment using FCE 21336, a new prolactin-lowering drug, and medroxyprogesterone acetate (MPA) in DMBA-induced tumors in rats.
Zaccheo T; Casazza AM; di Salle E; Pollini C; di Marco A
Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1193-7. PubMed ID: 6236980
[TBL] [Abstract][Full Text] [Related]
11. Effects of medroxyprogesterone acetate on DMBA-induced mammary tumors.
Racca S; Conti G; Crispino A; Gallo E; Di Carlo F
Chemioterapia; 1985 Jun; 4(3):236-8. PubMed ID: 3928182
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M
Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours.
Di Carlo F; Conti G; Giubertoni M; Muccioli G; Racca S
Cancer Chemother Pharmacol; 1991; 27(4):271-7. PubMed ID: 1825621
[TBL] [Abstract][Full Text] [Related]
14. Antitumor actions of toremifene in the 7,12-dimethylbenzanthracene (DMBA)-induced rat mammary tumor model.
Robinson SP; Mauel DA; Jordan VC
Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1817-21. PubMed ID: 2975594
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
Luo S; Stojanovic M; Labrie C; Labrie F
Int J Cancer; 1997 Nov; 73(4):580-6. PubMed ID: 9389575
[TBL] [Abstract][Full Text] [Related]
16. Effects of sequential and combined endocrine therapies on the growth of 7,12-dimethylbenz [alpha] anthracene-induced rat mammary carcinoma.
Iino Y; Ogawa T; Yoshida M; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1990 Sep; 20(3):259-62. PubMed ID: 2147726
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and pharmacological effects of toremifene metabolites.
Kangas L
Cancer Chemother Pharmacol; 1990; 27(1):8-12. PubMed ID: 2147128
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic activity of rat mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibition.
Oikawa T; Hiragun A; Yoshida Y; Ashino-Fuse H; Tominaga T; Iwaguchi T
Cancer Lett; 1988 Dec; 43(1-2):85-92. PubMed ID: 2462464
[TBL] [Abstract][Full Text] [Related]
19. [Changes of hormone receptor status in various treatment for human breast cancer and DMBA tumor of the rat].
Iino Y; Yamazaki K; Ishikawa H; Endo K; Arai T; Ogawa T; Hoshino K; Ishida T; Yokoe T; Takahashi T
Gan No Rinsho; 1984 Oct; 30(13):1633-7. PubMed ID: 6239934
[TBL] [Abstract][Full Text] [Related]
20. Expression of the c-Ha-ras and neu oncogenes in DMBA-induced, anti-estrogen-treated rat mammary tumors.
Vuorio T; Wärri A; Sandberg M; Alitalo K; Vuorio E
Int J Cancer; 1988 Nov; 42(5):774-9. PubMed ID: 2972630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
